CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Behavioral Activation (BA)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05098795
NCT05098795N/ACompleted
CompareCT.gov

Training Peer Recovery Coaches to Promote Retention and Adherence to Medications for Opioid Use Disorder Among Low-Income Adults

Henry Ford Health System·interventional·Posted Oct 28, 2021·Updated Mar 14, 2025

In Brief

A clinical study evaluating Behavioral Activation (BA) for Opioid Use. Completed, enrolled 29 participants across 1 site.

Detailed Summary

This project aims to implement a peer-led intervention to support retention and adherence to medications for opioid use disorder among low-income adults in Detroit, as well as a training manual for peer recovery coaches serving similar populations. The approach will serve as a guide to coaches in providing positive reinforcement and helping those in treatment to schedule and engage in valued activities. Researchers will examine the effectiveness of the intervention, supervision and training models, and share results with policymakers and treatment programs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Use
CountriesUnited States
CollaboratorsUniversity of Maryland, College Park

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 28, 2021
Enrollment StartDec 1, 2021
Primary CompletionAug 14, 2023
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.7 years ago

Interventions

Behavioral Activation (BA)behavioral

BA seeks to increase the positive reinforcement patients experience from their natural environment by promoting prosocial and valued experiences. BA has been found to improve substance use treatment retention and adherence, as well as medication adherence in low-income individuals with HIV/AIDS.